Project/Area Number |
11470337
|
Research Category |
Grant-in-Aid for Scientific Research (B).
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Urology
|
Research Institution | Osaka University |
Principal Investigator |
KOKADO Yukito Osaka University Graduate School of Medicine, Lecturer., 医学系研究科, 講師 (30186639)
|
Co-Investigator(Kenkyū-buntansha) |
NONOMURA Norio Osaka University Graduate School of Medicine, Professor Lecturer, 医学系研究科, 講師 (30263263)
TAKAHARA Shiro Osaka University Graduate School of Medicine, Associate Professor, 医学系研究科, 助教授 (70179547)
OKUYAMA Akihiko Osaka University Graduate School of Medicine, Professor, 医学系研究科, 教授 (20093388)
|
Project Period (FY) |
1999 – 2000
|
Project Status |
Completed (Fiscal Year 2000)
|
Budget Amount *help |
¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 2000: ¥2,100,000 (Direct Cost: ¥2,100,000)
|
Keywords | Chronic Rejection / Renal Transplantation / Glucocorticoid Receptor / Gel Shift / Immunosuppression / Stero'd / 転写因子 / 免疫抑制 |
Research Abstract |
Although chronic rejection is the most common reason for late allograft loss, its pathophysiology and etiology are unclear. Attempts to prevent chronic rejection are now focused on the modulation of transcriptional regulation. We evaluated the ability of glucocorticoid receptors (GR) to bind to the DNA binding site in peripheral blood mononuclear cells (PBMC) of five patients with chronic rejection and seven without it. Using an electrophoretic mobility shift assay, we measured the amount of nuclear glucocorticoid receptor capable of binding to its specific DNA recognition sequences, termed glucocorticoid response elements (GRE). GR binding was significantly greater in control patients than in those with chronic rejection (P<0.01). The retarded band was almost undetectable in two patients with chronic rejection even though they were taking more prednisolone than the seven control patients, all of whom had clearly identifiable retarded bands. These results suggest a decreased ability of GR to bind to GRE in chronic rejection, resulting in a reduced ability to block key proinflammatory promoter sites. This reduced binding may be one molecular basis of chronic rejection.
|